Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
Gabapentin is an anticonvulsive medication that received approval from the US Food and Drug Administration (FDA) in 1993 and has been available in generic form in the USA since 2004. Gabapentin was originally used as a muscle relaxant and an anti-spasmodic. However, it was later discovered that gabapentin has the potential of an anticonvulsive medication and can be used as an adjunct to more The gabapentin class action lawsuit was filed in 2022 against three pharmaceutical companies – Teva, Pfizer, and Greenstone – accusing them of misrepresenting the drug’s risks and overstating its benefits. A $190 million settlement has been reached in New York in a consumer fraud class action lawsuit pending against Pfizer which alleges the pharma giant engaged in tactics to delay market entry of generic versions of its epilepsy drug Neurontin. The lawsuit was filed by purchasers of Neurontin in 2002, claiming Pfizer Explore the potential for seeking compensation in gabapentin-related memory loss cases, including legal grounds, evidence, and filing deadlines. Los Angeles, CA: A $325 million preliminary settlement has been reached by Pfizer Inc and Warner-Lambert Co. LLC and plaintiffs who filed a consumer fraud class action lawsuit over the marketing A Diversified Practice The Schmidt Firm, PLLC has focused its practice on the representation of plaintiffs involved in both traditional personal injury and wrongful death litigation – involving medical malpractice, transportation accidents and nursing home abuse – as well as mass tort and toxic tort litigation – involving defective or dangerous pharmaceuticals, medical devices and toxic Gabapentin is an anticonvulsant medication used in the management of peripheral neuropathic pains, postherpetic neuralgia, and partial-onset seizures. Includes Gabapentin indications, dosage/administration, pharmacology, mechanism/onset/duration of action, half-life, dosage forms, interactions, warnings, adverse · The purpose of this notice is to alert you to a proposed settlement of a Class Action Lawsuit (the “Lawsuit”) brought by Direct Purchasers of Neurontin against Pfizer Inc. and Warner-Lambert Company LLC (collectively “Pfizer” or “Defendants”). The Lawsuit asserts that Pfizer violated antitrust laws relating to the sale of its prescription drug Neurontin. Gabapentin is an anti-epileptic drug, also called an anticonvulsant. It is used to treat some types of seizures and nerve pain caused by shingles. About Gabapentin Gabapentin, also known by its brand name Neurontin, is a medication primarily used to treat seizures, nerve pain, and certain other medical conditions. It has been found to be beneficial for patients suffering from postherpetic neuralgia and diabetic neuropathy. Gabapentin belongs to the class of drugs called anticonvulsants, which work by affecting the neurotransmitters in If you or a family member has had any of the aforementioned Neurontin adverse effects, especially if it was administered for an unapproved purpose, you should contact an experienced class action attorney to talk about your case and learn more about your options for compensation for a Neurontin injury. Legal Urge offers daily legal insights, news, and analysis to simplify complex laws. Explore expert content that informs, empowers, and sparks legal curiosity. UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY SUMMARY NOTICE OF PROPOSED CLASS ACTION SETTLEMENT, MOTION FOR ATTORNEYS’ FEES, AND HEARING REGARDING SETTLEMENT TO: ALL PERSONS OR ENTITIES WHO HAVE PURCHASED NEURONTIN DIRECTLY FROM PFIZER, INC. AND WARNER-LAMBERT AT ANY TIME DURING THE PERIOD OF DECEMBER 11, 2002, THROUGH AUGUST 31, 2008 AND WHO HAVE ALSO PURCHASED GENERIC Neurontin Lawsuit | 2025 Latest Updates The prescription pain reliever Neurontin (generic gabapentin) has recently been linked to an increased risk for Stevens-Johnson syndrome (SJS), a severe skin disorder in which the top layer of the skin dies, followed by a painful rash that spreads and blisters. The manufacturers of the drug Neurontin reached a $325 million class action lawsuit settlement Wednesday over allegations they fraudulently marketed the prescription drug, which is used to treat seizures, restless leg syndrome, and pain caused by shingles. If approved, third-party payers of the drug will be eligible to claim a cash award from the Neurontin class action settlement, announced ACCLaws.com offers expert legal insights, case analyses, and updates on major lawsuits, helping you stay informed and legally empowered. An $85 million class action has been reached with Sun Pharmaceutical Industries and Taro Pharmaceuticals. The class action lawsuit claims that certain generic drug manufacturers broke antitrust laws, leading to artificially higher prices for common generic drugs such as amphetamine, amoxicillin, gabapentin, baclofen, and others. Serving as co-lead counsel, Garwin Gerstein & Fisher LLP achieved a $190 million recovery for the Direct Purchaser Class. Direct purchasers claimed that Pfizer violated federal antitrust laws by illegally delaying the entry of generic versions of the prescription drug Neurontin. The active ingredient in Neurontin is gabapentin anhydrous. The lawsuit claimed that Pfizer delayed competition from
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |